GSE159339
In vitro exposure of leukocytes to HIV pre-exposure prophylaxis (PrEP) decreases mitochondrial function and alters gene expression profiles.
The use of antiretroviral therapy (ART) as pre-exposure prophylaxis (PrEP) is an effective strategy for preventing HIV acquisition.  The cellular consequences of PrEP exposure, however, have not been sufficiently explored to determine potential effects on health in individuals without HIV.  Peripheral blood mononuclear cells (PBMCs) from people without HIV  were exposed to tenofovir disoproxil fumarate (TDF) or emtricitabine (FTC) overnight.  Mitochondrial mass and function were measured by flow cytometry and Agilent XFp analyzer. Monocyte-derived macrophages (MDMs) were differentiated in 20% autologous serum for 5 days in the presence or absence of TDF or FTC, and surface markers, lipid uptake, and efferocytosis were measured by flow cytometry.  MDM gene expression was measured using RNAseq. Serum lipids were measured using mass spectrometry.  PBMCs exposed to TDF or FTC had decreased maximal oxygen consumption rate (OCR) and reduced mitochondrial mass.  Exposure to PrEP also increased reactive oxygen species (ROS) production from monocyte subsets.  Compared to MDMs cultured in medium alone, cells differentiated in the presence of TDF (829 genes) or FTC (888) genes had significant changes in gene expression.  Further, PrEP-exposed MDMs had decreased mitochondrial mass, and displayed increased lipid uptake and reduced efferocytosis.  Plasma biomarkers and lipid levels were also altered in vivo in individuals receiving a PrEP regimen.  Exposure of leukocytes to TDF or FTC resulted in decreased mitochondrial function, and altered functional and transcriptional profiles.  These findings may have important implications for the metabolic and immunologic consequences of PrEP in populations at risk for HIV acquisition. Overall design: Comparison of transcriptomic differences among monocyte-derived macrophages isolated from people without HIV and differentiated in the presence of PrEP (FTC and TDF)